Vol. 5 No. 2 (2019), ORIGINAL ARTICLES
Vol. 5 No. 2 (2019)

Vitamin D levels and its association with disease activity and quality of life in patients with juvenile idiopathic arthritis from ISSEMYM Toluca Maternal Children‘S Hospital

ORIGINAL ARTICLES
Published 2019-12-30
Samara Mendieta Zeron
Hospital Materno infantil ISSEMYM. Toluca, Estado de México
Mateo Sebastian Ruiz González
Hospital Materno infantil ISSEMYM. Toluca, Estado de México
Mónica Denisse Martín de Saro
Hospital Materno infantil ISSEMYM. Toluca, Estado de México
PDF (Spanish)

Keywords

Juvenile idiopathic Arthritis
vitamin D
Disease Activity
Quality of Life

How to Cite

1.
Mendieta Zeron S, Ruiz González MS, Martín de Saro MD. Vitamin D levels and its association with disease activity and quality of life in patients with juvenile idiopathic arthritis from ISSEMYM Toluca Maternal Children‘S Hospital. Rev. parag. reumatol. [Internet]. 2019 Dec. 30 [cited 2025 Oct. 6];5(2):43-50. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/107
APA ABNT Harvard Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Introduction: Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic inflammatory diseases in pediatrics, it is known that vitamin D has a direct effect on bone and muscle health, in the last decade functions have been found on the immune response and inflammation. Studies on chronic inflammatory diseases in pediatric age including JIA. The objective of this work is to determine if there is an association between vitamin D levels and disease activity and quality of life of patients with JiA.

Methods: Cohort, observational and analytical study where, prior approval by the Research Ethics Committee of the Hospital, vit D levels were determined and with the result CHAQ and JADAS71 tests were applied, in patients with JiA diagnosis, in the Pediatric Rheumatology consultation, information was collected from 28 patients diagnosed with JiA.

Results: An average of vitamin D levels of 21.53 ng / mL (+/- 7.04 ng / mL) was found with a minimum of 6.9 ng / mL and a maximum of 38.9 ng / mL. The results obtained for the quality of life evaluated through the CHAQ Questionnaire reported that 30.8% were with zero limitation, 30.8% mild limitation, 26.9% moderate limitation and 11.5% severe limitation. When using the JADAS test to assess disease activity, 42.3% of patients have inactive disease; 7.7% with low activity, 26.9% with moderate activity and 23.1% with high activity.

Conclusion: Although if it is found with an average in the population studied of vitamin D, in ranges of insufficiency, no relationship was found between these levels with the disease activity and quality of life of those of patients with JiA.

PDF (Spanish)

References

(1) Solís P. Artritis idiopática juvenil (AIJ); Pediatr Integral. 2013; XVII(1):24-33.

(2) Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care & Research 2016 Jan;68(1):1-26.

(3) Guraieb R, Guraieb P. Artritis reumatoide juvenil sistémica; Rev Med Inst Mex Seguro Soc. 2006;44(4):355-364.

(4) Arreguin R. Descripción de una cohorte de pacientes de artritis idiopática juvenil en el estado de Sonora, México; Rev Colomb Reumatol. 2016;23(4):236-241.

(5) Acalde M, Cantero S., Sánchez J, Gómez J. Nuevas perspectivas en el tratamiento de la artritis reumatoide; FARM HOSP (Madrid), 2003 Vol. 27. N.° 6, pp. 360-370.

(6) ernández V, Duarte C, Maldonado R, Rivas R, Clark P. Determinación de concentraciones séricas de 25(OH) D en niños con lupus eritematoso sistémico y artritis idiopática juvenil; Bol Med Hosp Infant Mex. 2015;72(2):99-105.

(7) García M., Mendoza C., Etchegaray I, Soto P, Jiménez EA, Robles V, et al. Insuficiencia y deficiencia de vitamina D en pacientes mexicanas con lupus eritematoso sistémico: prevalencia y relación con actividad de la enfermedad; Reumatol Clin. 2017;13(2):97-101.

(8) García M, Galvez J. Vitamina D y enfermedades autoinmunes reumáticas; Reumatol Clin. 2015;11(6):333-334.

(9) Torres del Pliego E, Nogués S. ¿Cómo utilizar la vitamina D y qué dosis de suplementación sería la más idónea para tener el mejor balance eficacia/seguridad?, Rev Osteoporos Metab Miner 2014. 6;(Supl 1):S1-4.

(10) Cortez F. Vitamina D y análogos; Dermatol Peru. 2014;24(1),27-33.

(11) Alcántara A. Vitamina D y dolor crónico. Rev Soc Esp Dolor. 2016;23(4):211-214.

(12) Ballina F. Medición de la calidad de vida en la artritis reumatoide. Rev Esp Reumatol. 2002;29(2):56-64.

(13) Brasil T, Ferriani V, Machado C. Health related quality of life survey about children and adolescents with juvenile idiopathic arthritis; Jornal de Pediatria. 2003;Vol.79,Nº1:63-68.

(14) Consolaro A, Giancane G, Shiappapietra B, Dava S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis; Pediatric Rheumatology. 2016;14:23.

(15) González B. La Artritis Idiopática Juvenil y su relevancia dentro de las Enfermedades Reumatológicas de la Infancia, Rev. Med. Clin. Condes. 2012;23(4)384-389.

(16) López D, Méndez L, Guagnelli M, Clarka P. Deficiencia de vitamina D en la edad pediátrica. Una oportunidad de prevención; Bol Med Hosp Infant Mex. 2015;72(4):225-234.

(17) Rosiles V, Salazar C, Velazquez R, Ruiz R, Clark P. Determinación de concentraciones séricas de 25(OH) D en niños con lupus eritematoso sistémico y artritis idiopática juvenil. Boletín Médico del Hospital Infantil de México. 2015;72(2):99-105.

(18) Flores M., Sánchez N., Lozada A. Concentraciones séricas de vitamina D en niños, adolescentes y adultos mexicanos. Resultados de la ENSANUT 2006.

Downloads

Download data is not yet available.